Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
about
Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literatureThe expression of genes involved in glucose metabolism is affected by N-methyl-D-aspartate receptor antagonism: a putative link between metabolism and an animal model of psychosisIntravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.Refractory and super-refractory status epilepticus--an update.Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys.17β-Oestradiol Protects Primary-Cultured Rat Cortical Neurons from Ketamine-Induced Apoptosis by Activating PI3K/Akt/Bcl-2 Signalling.Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trialBrain and cognition abnormalities in long-term anabolic-androgenic steroid users.Oral ketamine for children with chronic pain: a pilot phase 1 studyAntidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial.Ketamine for the treatment of chronic non-cancer pain.Pharmacotherapy for acute pain in children: current practice and recent advances.Ketamine in pain management.Baicalin Attenuates Ketamine-Induced Neurotoxicity in the Developing Rats: Involvement of PI3K/Akt and CREB/BDNF/Bcl-2 Pathways.Working in the dark: a hermeneutic inquiry into health professionals' stories of ketamine sedation with children.Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophrenia.NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation.
P2860
Q27007770-4CE47E06-98B2-478E-A2C0-DC131E99FE4AQ28574077-C8E7FEB6-14F6-4A16-8488-FA8009484FD4Q30411523-1BBC9457-7E0A-49E7-93BF-57AE8EAC7A20Q30807706-886A1922-F686-4603-A1E0-7D8AAE2D1460Q34768212-32F0C424-2B4A-4E05-AE5C-11A28C02B36CQ34975079-01C634E2-1509-46F9-97DF-2CF48F697828Q35200000-C1C5E850-575C-4339-B64A-BB1BE0393C0AQ35690343-8594ED2B-7EA4-42B7-8C56-61EC4F2CA135Q37237499-259A7ADF-FEF1-4DEC-9494-C7F181A3D052Q37725117-C623FF4A-7CDA-4C90-86B6-0F7197FA66B2Q37786623-FB5D4CC8-AA7B-4D3F-8C8D-9F349F5E63C5Q37831316-38E083E9-73BD-498F-94CC-7FD4C6041512Q38105649-F2522657-6269-460F-B5EC-71BC8C48F176Q39955764-D719A79F-1D10-43D6-BF25-DAB3D8403698Q47937766-AE804921-E16D-481C-A31A-CC1A5FBEB598Q48181141-243F53CE-8F9E-4367-8B60-DE79DB01A220Q55514073-0D430413-E83E-4CA1-8843-363AB6235CF8
P2860
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@ast
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@en
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@nl
type
label
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@ast
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@en
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@nl
prefLabel
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@ast
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@en
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@nl
P1476
Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine
@en
P2093
Charles J Coté
Steven M Green
P304
P356
10.1016/J.ANNEMERGMED.2008.10.003
P407
P577
2009-08-01T00:00:00Z